Compared effects of calcium and sodium polystyrene sulfonate on mineral and bone metabolism and volume overload in pre-dialysis patients with hyperkalemia
Compared effects of calcium and sodium polystyrene sulfonate on mineral and bone metabolism and volume overload in pre-dialysis patients with hyperkalemia
复制标题
聚苯乙烯磺酸钙和聚苯乙烯磺酸钠对透析前高钾血症患者矿物质和骨代谢以及容量超负荷的影响比较
DOI:
10.1007/s10157-017-1412-y
复制
发表时间:
2017
影响因子:
2.3
通讯作者:
Kei Fukam
中科院分区:
文献类型:
--
作者:
Yosuke Nakayama;Kaoru Ueda;Sho-ichi Yamagishi;Miki Sugiyama;Chika Yoshida;Yuka Kurokawa;Nao Nakamura;Tomofumi Moriyama;Goh Kodama;Tomohisa Minezaki;Sakuya Ito;Akiko Nagata;Kensei Taguchi;Junko Yano;Yusuke Kaida;Kazutaka Shibatomi;Kei Fukam
Background Hyperkalemia is prevalent in end-stage renal disease patients, being 2 involved in life-threatening arrhythmias. Although polystyrene sulfonate (PS) is 3 commonly used for the treatment of hyperkalemia, direct comparison of effects between 4 calcium and sodium PS (CPS and SPS) on mineral and bone metabolism has not yet 5 been studied. Methods In a randomized and crossover design, 20 pre-dialysis patients 6 with hyperkalemia (> 5 mmol/l) received either oral CPS or SPS therapy for 4 weeks. 7 Results After 4 week-treatments, there was no significant difference of changes in 8 serum potassium (K) from the baseline (ΔK) between the two groups. However, SPS 9 significantly decreased serum calcium (Ca) and magnesium (Mg) and increased intact 10 parathyroid hormone (iPTH) values, whereas CPS reduced iPTH. ΔiPTH was inversely 11 correlated with ΔCa and ΔMg (r=-0.53 and r=-0.50, respectively). Furthermore, sodium 12 (Na) and atrial natriuretic peptide (ANP) levels were significantly elevated in patients 13 with SPS, but not with CPS, whereas ΔNa and ΔANP were significantly correlated with 14 each other in all the patients. We also found that ΔNa and Δ (Na to chloride ratio) were 15 positively correlated with ΔHCO3-. In artificial colon fluid, CPS increased Ca and 16 decreased Na. Furthermore, SPS more decreased K, Mg, and NH3. Conclusion 17 Compared with SPS, CPS may be safer for the treatment of hyperkalemia in pre-dialysis 18 patients, because it did not induce hyperparathyroidism or volume overload. 19